
		NDA Regulatory Affairs

		NDA Advisory Board

		NDA Biopharmaceuticals

		NDA Pharmacovigilance

		NDA Quality Assurance

		NDA Readability

		NDA Academy

		About NDA

		Contact Us

		Job Opportunities

		Press

NDA - Europe's leading Regulatory Service provider

If anyone can make sure that the best possible medicines reach the patients without unnecessary delay – it’s NDA.

In all we do at NDA, our aim is to shorten the expensive and time consuming process of getting effective and reliable medicines to the market.

NDA can achieve this by providing our clients with an extensive portfolio of services that are optimised to meet the standards of the regulatory authorities.

NDA's clients benefit from our input into development plans and regulatory assistance during the complete life span of their products.

In short, NDA strive to bridge the communication gap between the regulated and the regulators – to the ultimate benefit of patients

Let’s not keep them waiting.
Let’s bring medicines to the world.

16 March 2010, FORUM: "Elektronisches Dokumentenmanagement zwischen F&E und Zulassung", Munich, Germany

Mrs Inge Neubauer, Expert in CMC & eCTD Services, NDA, will present:

Praxisbeispiele - Template - basierte Dokumentenerstellung
The seminar will be held in German.

For registration and detailed programme please click here.

Electronic Publishing Services at the NDA Group

Let us help your organisation benefit from eCTD.

more information

The NDA Group is an independent consulting organization focused on the strategic and operational aspects of regulatory affairs. NDA provides assistance to both the Pharmaceutical Industry as well as Regulatory Agencies. The ultimate objective of NDA is to help to develop better medicines that reach the patient without unnecessary delay. NDA achieves this objective by critically reviewing client project development plans with the aim that they are optimized to meet the needs of regulatory authorities and then to help to implement those strategies. NDA strives to bridge the communication gap between "the regulators" and "the regulated" to the benefit of patients.

The NDA Group provides services within several different areas such as regulatory affairs, pharmacovigilance and patient safety, readability testing, quality assurance. NDA works with traditional pharmaceuticals, biopharma, medical devices and production processes within the pharmaceutical industry.

The NDA Group also provides expert and strategical advice on development and regulatory strategies and assists the pharmaceutical industry with qualified training.